Biotech China 2014

Proteomics: Bristol-Myers Squibb

Total Score People Score Events Score
12 12 9
Date Event Presentation Speakers
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 1 Key Factors to be Considered for Clinical Development in Emerging Markets Ruiping Dong
1 Chairperson's Opening Remarks Ruiping Dong
January 26, 2009 Biomarker Assay Development Moving Beyond Fit-for-Purpose: Use of Lean Practices to Accelerate Biomarker Assay Development Russell S Weiner
Validation and Implementation of Flow Cytometric Assay to Evaluate Pharmacodynamic Biomarkers in Clinical Study Dianna Wu
January 26, 2009 Translational Cancer Medicine COMBINATION THERAPIES : Combination Approaches for the Treatment of Solid Tumors: Opportunities and Obstacles in the Era of Targeted Therapy Jon M Wigginton
January 12, 2009 Model Based Drug Development IN SILICO MODELING : Using Innovative Modeling and Simulation Strategies in the Development of Therapeutic Monocolonal Antibodies Chee Ng
September 29, 2008 Genomic Biomarkers Discovery of Gene Expression-Based Pharmacodynamic Biomarkers in Tumor Immunotherapies Zenta Tsuchihashi
December 1, 2007 47TH American Socieity of Cell Biology Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Lois Burton
September 30, 2007 BioProcess International Conference & Exhibition Production & Economics of Biopharmaceuticals, Strategies for Flexible Facility Design and Capacity Optimization (07:00 - 11:30) Abhinav Shukla
Strategies for Flexible Facility Design and Capacity Optimization: Chairperson's Remarks Abhinav Shukla
Market Forces and Technology Developments Affecting Economics of Biopharmaceuticals : Leveraging Contract Manufacturing as a Market Entry Strategy for Biologics Abhinav Shukla
Production & Economics of Biopharmaceuticals ; Market Forces and Technology Developments Affecting Economics of Biopharmaceuticals (08:00 - 11:30) Abhinav Shukla
Plenary Session : Keynote Presentations and Featured Discussion (14:00 - 18:00) Abhinav Shukla, Tobias Massa
Plenary Session ; Keynote Presentations and Featured Discussion : Industry Expectations of the New Pharmaceutical Quality Assessment System Tobias Massa
Plenary Session ; Keynote Presentations and Featured Discussion : Interactive Panel Discussion on the Future of Downstream Processing: How Best to Handle Higher Bioreactor Outputs and Greater Product Demands Abhinav Shukla
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: Changing the Benefit/Risk Profile Using Pharmacogenetics (09:05-09:35) Koustubh Ranade
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Koustubh Ranade
Third annual Genomic Biomarkers: VALIDATION OF GENOMIC BIOMARKERS: Discovery and Validation of Biomarkers Affected by Brivanib and Erbitux (11:30-12:00) J. Suso Platero
Third annual Genomic Biomarkers: VALIDATION OF GENOMIC BIOMARKERS (11:30-14:00) J. Suso Platero
June 23, 2007 Mechanism and Regulation of Prokaryotic Transcription “DNA translocation and transcription-coupled DNA repair” Nigel Savery
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.